On March 31, 2022, Mary Ann Gray, Ph.D., informed the board of directors of Sarepta Therapeutics, Inc. that she has elected to not stand for re-election and will complete her term on the board at the conclusion of the company's 2022 annual meeting of stockholders. Dr. Gray's decision to not stand for re-election was not because of a disagreement with the company on any matter relating to the Company's operations, policies, or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.8 USD | +4.28% | +5.12% | +34.58% |
30/05 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
30/05 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.58% | 12.27B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics, Inc. Announces Not Stand for Re-Election of Mary Ann Gray as Board of Director